News

Seven of London’s leading medical research institutions created an independent company to broker partnerships in the field of genetics and genomics.

Industry in Europe and elsewhere will need to act in concert to apply the recommendations iof the report into the disastrous TGN 1412 drugs trial.

The US federal spending on R&D continues its skyward progression.

The Czech Republic is another magnet for new R&D operations.

Start up funds for PhD students in China.

The Council for Science and Technology has added to the advice on how to create healthier Britons.

Boosting innovation in the European Union may be a top political priority but heads of state and government from the 25 countries in the Union had little time for the topic at this week’s summit in Brussels.